Nephrocare Health Services Limited Stock
Equities
NEPHROPLUS
INE428V01029
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 562.10 INR | +1.77% |
|
-5.34% | +19.93% |
| Capitalization | 55.42B 603M 522M 473M 454M 827M 864M 5.59B 2.23B 26.55B 2.26B 2.22B 95.21B | P/E ratio 2026 * |
68.2x | P/E ratio 2027 * | 29.5x |
|---|---|---|---|---|---|
| Enterprise value | 55.42B 603M 522M 473M 454M 827M 864M 5.59B 2.23B 26.55B 2.26B 2.22B 95.21B | EV / Sales 2026 * |
5.49x | EV / Sales 2027 * | 4.9x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nephrocare Health Services Limited
| 1 day | +1.77% | ||
| 1 week | -5.34% | ||
| Current month | -5.34% | ||
| 1 month | +5.99% | ||
| Current year | +19.93% |
| 1 week | 545.5 |  | 596 |
| 1 month | 516.7 | | 616 |
| Current year | 457 | | 616 |
| 1 year | 446 | | 616 |
| 3 years | 446 | | 616 |
| 5 years | 446 | | 616 |
| 10 years | 446 | | 616 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kishore Kathri
CMP | Compliance Officer | - | 2025-07-15 |
| Chief Operating Officer | - | 2019-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Vikram Vuppala
CHM | Chairman | 49 | 2009-12-18 |
| Director/Board Member | 48 | 2014-10-09 | |
| Director/Board Member | 60 | 2021-02-10 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | -5.34% | - | - | 603M | |
| -1.00% | -2.52% | +20.79% | +50.93% | 20.12B | |
| +0.30% | -3.87% | -26.60% | -57.02% | 13.73B | |
| -2.24% | -2.52% | +57.64% | +126.68% | 11.96B | |
| -1.13% | -1.71% | +22.53% | +73.88% | 12.17B | |
| -1.21% | +0.40% | +7.63% | +94.81% | 10.7B | |
| -0.51% | -11.01% | -18.49% | -30.71% | 9.69B | |
| -1.91% | -4.11% | +39.36% | +221.92% | 7.57B | |
| -3.33% | -9.73% | -25.16% | - | 7.26B | |
| +1.18% | +3.37% | +29.80% | -33.77% | 7.07B | |
| Average | -0.80% | -3.41% | +11.94% | +55.84% | 10.09B | |
| Weighted average by Cap. | -1.02% | -2.57% | +12.42% | +51.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.1B 110M 95.12M 86.14M 82.7M 151M 157M 1.02B 407M 4.84B 413M 404M 17.35B | 11.32B 123M 107M 96.54M 92.68M 169M 176M 1.14B 456M 5.42B 463M 453M 19.45B |
| Net income | 1.11B 12.13M 10.49M 9.5M 9.12M 16.63M 17.37M 112M 44.91M 534M 45.53M 44.56M 1.91B | 1.94B 21.09M 18.24M 16.52M 15.86M 28.92M 30.2M 195M 78.09M 928M 79.16M 77.47M 3.33B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-06 | 562.10 ₹ | +1.77% | 25,692 |
| 26-03-05 | 552.30 ₹ | -1.02% | 46,505 |
| 26-03-04 | 558.00 ₹ | -4.26% | 76,249 |
| 26-03-02 | 582.85 ₹ | -1.84% | 94,331 |
| 26-02-27 | 593.80 ₹ | -2.09% | 124,914 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
552.30INR
Average target price
615.00INR
Spread / Average Target
+11.35%
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEPHROPLUS Stock
Select your edition
All financial news and data tailored to specific country editions
